Article Details

Pharma Stock Roundup: RHHBY's Alzheimer's Study Failure, EU Nod for SNY's Enjaymo

Retrieved on: 2022-11-18 20:19:28

Tags for this article:

Click the tags to see associated articles and topics

Pharma Stock Roundup: RHHBY's Alzheimer's Study Failure, EU Nod for SNY's Enjaymo. View article details on hiswai:

Excerpt

The FDA approved AstraZeneca's AZN Imfinzi/Imjudo cancer combination for ... cancer drug Lynparza and AstraZeneca's two other cancer drugs Enhertu ...

Article found on: www.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up